Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eledon Pharmaceuticals (ELDN) Shares Outstanding (Weighted Average) (2016 - 2026)

Eledon Pharmaceuticals filings provide 5 years of Shares Outstanding (Weighted Average) readings, the most recent being $4.7 million for Q4 2017.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1122.12% to $4.7 million in Q4 2017 year-over-year; TTM through Dec 2017 was $4.7 million, a 1122.12% increase, with the full-year FY2017 number at $4.7 million, up 1122.12% from a year prior.
  • Shares Outstanding (Weighted Average) hit $4.7 million in Q4 2017 for Eledon Pharmaceuticals, up from $3.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $22.6 million in Q1 2016 to a low of $77856.0 in Q2 2016.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $1.7 million (2014), compared with a mean of $7.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 99.65% in 2016 and later surged 4627.45% in 2017.
  • Eledon Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $416037.0 in 2013, then soared by 1454.98% to $6.5 million in 2014, then skyrocketed by 247.56% to $22.5 million in 2015, then plummeted by 98.3% to $382747.0 in 2016, then soared by 1122.12% to $4.7 million in 2017.
  • The last three reported values for Shares Outstanding (Weighted Average) were $4.7 million (Q4 2017), $3.8 million (Q3 2017), and $2.3 million (Q2 2017) per Business Quant data.